Non-Hodgkin's Lymphoma

Non-Hodgkin’s lymphoma (NHL) begins in the lymphatic system, part of the body’s immune system.  Non-Hodgkin’s lymphoma is slightly more common in men than in women, and more than 90 percent of newly diagnosed NHL cases occur in adults.  Because there is lymphatic tissue throughout the body, adult NHL can begin in almost any part of the body.  Childhood NHL and its treatment are often different from adult NHL.

At The James, we have a team of physicians and physician-researchers who specialize in diagnosing and treating non-Hodgkin’s lymphoma. With research and treatment areas under one roof, we are better able to translate research advances to patient care – so our team of specialists can provide the best possible care for patients with non-Hodgkin’s lymphoma.

As one of only four institutions approved by the National Cancer Institute (NCI) to conduct phase I and II clinical trials on NCI sponsored anticancer agents, the OSUCCC – James has access to more leading-edge targeted cancer therapies than most hospitals across America. That translates to better outcomes, fewer side effects and more hope. Search open cancer clinical trials​.​

This section of the Web site will give you access to:

If you have questions about non-Hodgkin's lymphoma, please call The James Line – a free cancer information resource and physician referral service – at 614-293-5066 or 1-800-293-5066 (outside Franklin County) or e-mail nowThe James Line oncology nurses can be reached Monday-Friday 8:00 a.m.-5:00 p.m. (except weekends and holidays).

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu